Healio

Studies examine AcrySof lenses in children

Evidence points to the decrease of posterior capsule opacification (PCO) in adults receiving the AcrySof (Alcon, Fort Worth, Texas) IOL, but pediatric surgeons are hoping to evaluate the same results ...
Business Wire

Alcon Launches AcrySof ReSTOR Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
Medscape

Monte Carlo Simulation of Expected Outcomes with the AcrySof

Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
Healio

AcrySof IQ aspheric lens designated as new technology IOL

Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — An aspheric IOL has been recognized as belonging to the subset of new technology IOLs that ...
Medscape

Rotational Stability of the AcrySof SA60TT Toric Intraocular Lenses: A Cohort Study

Background: To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week. Methods: A ...
Yahoo Finance

Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses The ...
Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
The Financial

Alcon AcrySof IQ PanOptix trifocal intraocular lens shows superior visual performance in head-to-head trial post-cataract surgery

The FINANCIAL — Basel, June 18, 2018 Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the ...
Business Insider

Alcon Canada introduces AcrySof IQ Vivity, the only presbyopia-correcting intraocular lens with X-WAVE technology

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...
Nasdaq

Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...